These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi. Fowlkes A, Witte D, Beeler J, Audet S, Garcia P, Curns A, Yang C, Fudzulani R, Broadhead R, Bellini WJ, Cutts F, Helfand RF. J Infect Dis; 2011 Jul; 204 Suppl 1():S149-57. PubMed ID: 21666156 [Abstract] [Full Text] [Related]
3. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Arpadi SM, Markowitz LE, Baughman AL, Shah K, Adam H, Wiznia A, Lambert G, Dobroszycki J, Heath JL, Bellini WJ. Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602 [Abstract] [Full Text] [Related]
4. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. Moss WJ, Scott S, Mugala N, Ndhlovu Z, Beeler JA, Audet SA, Ngala M, Mwangala S, Nkonga-Mwangilwa C, Ryon JJ, Monze M, Kasolo F, Quinn TC, Cousens S, Griffin DE, Cutts FT. J Infect Dis; 2007 Aug 01; 196(3):347-55. PubMed ID: 17597448 [Abstract] [Full Text] [Related]
5. Immune responses to measles immunization and the impacts on HIV-infected children. Thaithumyanon P, Punnahitananda S, Thisyakorn U, Praisuwanna P, Ruxrungtham K. Southeast Asian J Trop Med Public Health; 2000 Dec 01; 31(4):658-62. PubMed ID: 11414407 [Abstract] [Full Text] [Related]
6. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S. Pediatr Infect Dis J; 2003 Aug 01; 22(8):691-5. PubMed ID: 12913768 [Abstract] [Full Text] [Related]
7. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM. J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246 [Abstract] [Full Text] [Related]
8. Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules. Fowlkes AL, Witte D, Beeler J, Audet SA, Broadhead R, Bellini WJ, Cutts F, Helfand RF. Vaccine; 2016 Mar 14; 34(12):1459-64. PubMed ID: 26873052 [Abstract] [Full Text] [Related]
9. Measles immunity in HIV-infected children. Walter EB, Katz SL, Bellini WJ. Pediatr AIDS HIV Infect; 1994 Oct 14; 5(5):300-4. PubMed ID: 11361371 [Abstract] [Full Text] [Related]
10. Immune status following measles vaccination in infants and evaluation for the need of revaccination. Dutta AK, Singhal PK, Khare S, Kumari S, Mathur R, Mullick DN. Indian Pediatr; 1989 Aug 14; 26(8):765-72. PubMed ID: 2620977 [Abstract] [Full Text] [Related]
11. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Markowitz LE, Albrecht P, Rhodes P, Demonteverde R, Swint E, Maes EF, Powell C, Patriarca PA. Pediatrics; 1996 Jan 14; 97(1):53-8. PubMed ID: 8545224 [Abstract] [Full Text] [Related]
12. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Nkrumah FK, Osei-Kwasi M, Dunyo SK, Koram KA, Afari EA. Bull World Health Organ; 1998 Jan 14; 76(4):353-9. PubMed ID: 9803586 [Abstract] [Full Text] [Related]
13. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age. Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, Whittle H, Aaby P. J Infect Dis; 2014 Sep 01; 210(5):693-700. PubMed ID: 24688075 [Abstract] [Full Text] [Related]
14. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C. N Engl J Med; 1985 Aug 29; 313(9):544-9. PubMed ID: 4022091 [Abstract] [Full Text] [Related]
15. [Responses to triple viral and tetanus vaccination in HIV-infected children]. Echeverría Lecuona J, Aldamiz-Echevarría Azuara L, Cilla Eguiluz G, Pérez Trallero E. An Esp Pediatr; 1996 Apr 29; 44(4):317-20. PubMed ID: 8849078 [Abstract] [Full Text] [Related]
16. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART. Belaunzarán-Zamudio PF, García-León ML, Wong-Chew RM, Villasís-Keever A, Cuellar-Rodríguez J, Mosqueda-Gómez JL, Muñoz-Trejo T, Escobedo K, Santos JI, Ruiz-Palacios GM, Sierra-Madero JG. Vaccine; 2009 Nov 23; 27(50):7059-64. PubMed ID: 19799846 [Abstract] [Full Text] [Related]
17. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Borràs E, Urbiztondo L, Costa J, Batalla J, Torner N, Plasencia A, Salleras L, Domínguez À, Working Group for the Study of Measles Immunity in Children. Epidemiol Infect; 2012 Sep 23; 140(9):1599-606. PubMed ID: 22074684 [Abstract] [Full Text] [Related]
19. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. Brunell PA, Vimal V, Sandu M, Courville TM, Daar E, Israele V. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec 15; 10(5):540-8. PubMed ID: 8548333 [Abstract] [Full Text] [Related]
20. Antibody response after measles immunization. Ariyasriwatana C, Kalayanarooj S, Pattamadilok S. J Med Assoc Thai; 2003 Aug 15; 86 Suppl 3():S701-6. PubMed ID: 14700170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]